Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
Time spent managing the transfer of information and results between LIMS and their Empower® chromatography data software was giving scientists less time to run samples and was creating delays for end-users who needed to work with the sample results. With implementation of a LimsLink CDS embedded interface they now have more time to spend on analysis, results are delivered to clients faster, manual errors are eliminated and the overall cost of chromatography data management has been reduced.